20.42.Z - Manufacture of cosmetics and toilet preparations
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47 - Retail trade
71 - Architectural and engineering activities, technical testing and analysis
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | 0 | 0,2 | -∞ |
Gross profit (loss) | -0,1 | 0 | 0,1 | -∞ |
EBITDA | -0 | 0 | 0,2 | -∞ |
Short time liabilities | 0,1 | 0,2 | 0,1 | -36,9 |
Other operating costs | 0 | 0 | 0 | -∞ |
Equity capital | 0,3 | 0,7 | 0,8 | 13 |
Operating profit (EBIT) | -0,1 | 0 | 0,2 | -∞ |
Assets | 2,1 | 3,8 | 4,8 | 26,5 |
Net profit (loss) | -0,1 | 0,4 | 0,1 | -76,1 |
Cash | 0,9 | 1 | 0,3 | -70,8 |
Net income from sale | 0 | 0 | 1 | -∞ |
Liabilities and provisions for liabilities | 1,7 | 3,1 | 4 | 29,4 |
Working assets | 1,1 | 1,2 | 0,6 | -50,1 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | -27,3 | 54,1 | 11,5 | -42,6 |
Equity capital to total assets | 15,3 | 18 | 16,1 | -1,9 |
Gross profit margin | -193,5 | 9,4 | 202,9 | |
EBITDA Margin | -102,3 | 19,4 | 121,7 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 769 | 2 147 483 648 | 43 | -2 147 483 605 |
Current financial liquidity indicator | 11.257373809814453 | 6.173214912414551 | 4.890091896057129 | -1,3 |
Net dept to EBITDA | 20.398983001708984 | -1.4787288904190063 | -21,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane